2021 American Transplant Congress
Early Review of Liver Acuity Circles Allocation
1UNOS, Richmond, VA, 2Mayo Clinic, Rochester, MN, 3UCHealth, Aurora, CO, 4BSWHealth, Dallas, TX
*Purpose: Acuity circles (AC) allocation was implemented on February 4, 2020, followed shortly by the declaration of national emergency for COVID-19. The goal of this…2021 American Transplant Congress
Donor-specific Anti-HLA Alloantibody in Kidney Transplant Recipients with COVID-19 Exhibit a Different Immunoglobulin Class and Subclass Profile When Compared to Anti-SARS-CoV-2 Antibodies
*Purpose: Both anti-HLA and anti-SARS-CoV-2 antibodies target protein antigens. The aim of the present study was to compare the class and subclass profile of such…2021 American Transplant Congress
Attitudes Regarding Transplantation During the Pandemic: Give Me My Kidney Now!
1Houston Methodist Research Institute, Houston, TX, 2Houston Methodist Hospital, Houston, TX
*Purpose: The transplant community faces ongoing challenges regarding the conduct of organ transplantation during the COVID-19 pandemic, and patient treatment preferences during the pandemic require…2021 American Transplant Congress
Seasonality of Mortality for Solid Organ Waitlist Candidates
*Purpose: Analysis of the impact of policies or natural occurrences on transplant system outcomes requires comparison of a treatment (post-policy) period to a control (pre-policy)…2021 American Transplant Congress
Short Term Outcomes in Previously Covid Positive Kidney Transplant Recipients in Pre-vaccine Era
Henry Ford Transplant Institute, Detroit, MI
*Purpose: To study clinical characteristics and short-term outcomes in kidney transplant recipients who were previously infected with SARS-CoV-2*Methods: In this retrospective, single-center case-series, we identified…2021 American Transplant Congress
Quantification of Multiple Isotypes of Anti-SARS-CoV-2 Antibodies in Kidney Transplant Recipients
*Purpose: Solid organ transplant recipients are at increased risk of severe outcomes with infection by SARS-CoV-2, the etiologic agent of COVID-19. Antibodies directed against the…2021 American Transplant Congress
Liver and Kidney Transplantation During the Covid-19 Pandemic Period: A Single Center Experience
*Purpose: Introduction: Beginning of this year, when the Covid-19 pandemic has first started, it had the immediate effect of severely reducing living and deceased organ…2021 American Transplant Congress
Sars-cov-2 Stat Testing for Organ Donation; One Laboratory’s Experience
*Purpose: The COVID-19 pandemic took the U.S. by storm. The Transplant Community had to navigate through unprecedented scenarios in order to continue the life-saving mission…2021 American Transplant Congress
Racial/ethnic Disparities Among Renal Transplant Recipients with Diabetes, Hypertension, and/or Dyslipidemia Due to Medicare Part D Star Ratings Criteria
*Purpose: Medication adherence is critical to positive outcomes in renal transplant recipients (RTRs), and policies have been designed encouraging adherence. For example, Medicare Part D…2021 American Transplant Congress
The Calculated Panel of Incompatible Epitopes (cPIE) in the Service of Equitable Access to Transplantation
*Purpose: To inform on feasibility of eplet matching, we developed the calculated Panel of Incompatible Epitopes (cPIE), an algorithm informing on the likelihood of identifying…
- « Previous Page
- 1
- …
- 265
- 266
- 267
- 268
- 269
- …
- 1683
- Next Page »